Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE : BHVN)

( )
BHVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.88%162.110.7%$1086.81m
MRKMerck & Co., Inc. -0.79%76.620.7%$1018.44m
PFEPfizer Inc. -1.77%38.780.9%$918.56m
LLYEli Lilly & Co. -1.68%218.471.1%$906.20m
ABBVAbbVie, Inc. -1.59%113.071.9%$727.29m
BMYBristol-Myers Squibb Co. -0.34%66.541.0%$643.98m
AZNAstraZeneca Plc 0.03%58.371.2%$408.15m
ANVSAnnovis Bio, Inc. 2.78%92.550.0%$317.09m
OGN -4.74%29.970.0%$312.13m
NVSNovartis AG -1.21%93.010.2%$178.45m
GSKGlaxoSmithKline Plc -1.80%39.840.2%$160.18m
ORPHOrphazyme A/S -49.66%7.330.0%$152.39m
NOVNNovan, Inc. 0.18%10.875.8%$140.49m
CVACCureVac NV 7.11%61.940.0%$108.62m
CNSTConstellation Pharmaceuticals, Inc. -0.18%33.760.0%$107.09m

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.